France Archives

enterome pierre belichard microbiome crohns ibd

News and Trends 3 Feb 2016

Meet the CEO of Europe’s Leading Microbiome Biotech

We met Pierre Belichard, the CEO of Enterome, last week to discuss the increasingly famous trend in the Human Microbiome and how this is impacting therapeutics in Crohn’s disease, the understanding of Medical Microbiomics and investment in this field of Biotech. Enterome, established in 2012, is a French biotech that is hot at the moment, […]

February 3, 2016 - 5 minutesmins - By Philip Hemme

kasios bone therapeutics 3D print osteoporosis

News and Trends 2 Feb 2016

From Belgium: 3D-Bioprinted ‘Waffle’ to Fix Broken Bones

Bone Therapeutics (Belgium) is a cell therapy biotech working on bone fracture repair which has now extended its collaboration with Kasios (France), to develop next-generation bone disease therapy with 3D-Bioprinting technology. The current standard-of-care in the Bones field involves major surgeries and (consequently) long recovery time. Bone Therapeutics is, therefore, developing a range of regenerative products containing osteoblasts (bone-forming cells), which […]

February 2, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 28 Jan 2016

This Young CEO is Making Biotech Popular in France

Biotech is often a touchy subject for conversation, which is not always understood by the general public, and even less appreciated… Xavier Duportet, the 28-year-old French founder of Eligo Bioscience (read Our interview here) was this week on the hugely popular French TV-show Le Petit Journal to talk about Biotech. This program is the most popular such medium […]

January 28, 2016 - 2 minutesmins - By Philip Hemme

News and Trends 28 Jan 2016

Viral Immunotherapy Trial Failure Causes French Biotech Stocks to Drop 43%

Genticel (France) is a clinical biotech developing a cervical cancer immunotherapy against the Human papillomavirus. However, their 24-month phase II trial has failed to meet primary endpoint at its halfway point, and their stocks dropped 43% overnight. Around 70% of cervical cancer cases are caused by 2 types of Human papillomavirus (HPV): 16 and 18. And among the 300 million women around the […]

January 28, 2016 - 3 minutesmins - By Dani Bancroft

Twist dna bioscience sequencing micrarray emily leproust

News and Trends 27 Jan 2016

French Investor Leads €60M Financial Round for the Future of DNA Synthesis

Twist Bioscience is a San Francisco Biotech accelerating science and innovation through rapid, high-quality DNA synthesis piece of tech. And now, Twist has completed a $61 million Series D round. An improved silicon-based design compared to the traditional 96-well plates could do wonders for DNA synthesis, including major improvements in cost and time of the process. And the […]

January 27, 2016 - 3 minutesmins - By Dani Bancroft

lupus neovacs stellar limpet protein autoimmune immunotherapy biotech

News and Trends 21 Jan 2016

Fighting Lupus with an Autoimmune Disease Vaccine that Uses Limpet Proteins

Neovacs in Paris (France) investigates immunotherapies for the treatment of autoimmune diseases and today signed a partnering agreement with the molluscan protein manufacturer, Stellar Biotechnologies (US). This joint venture will operate under the name of Neostell SAS, and it will be owned 30:70, the majority going to Neovacs. Neovacs is a biotech focused on an active immunotherapy technology platform (Kinoids) […]

January 21, 2016 - 2 minutesmins - By Dani Bancroft

amoeba water treatment biocide legionella twb

News and Trends 20 Jan 2016

How is Using Amoeba to Fight off Legionella in Water Tanks a White Biotech Solution?

A French Green-Biocide Specialist, Amoéba (France) is using these voracious single celled predators to tackle water-borne diseases, with added help from the Toulouse White Biotech (TWB). Toulouse White Biotechnology (TWB), a pre-industrial demonstrator, and Amoéba have been working together for nearly 18 months in order to produce a revolutionary biocide (using living amoeba). This biocide would […]

January 20, 2016 - 3 minutesmins - By Dani Bancroft

HIV abivax Alexey Kashpersky abx464 trial antiviral

News and Trends 13 Jan 2016

A Phase II HIV Antiviral from France Has Promising Results

Abivax in Paris (France) has released its phase IIa clinical results for an antiviral therapy for patients with HIV infection, which could potentially take a corner in an annual $18Bn market. HIV and AIDs have a long-standing history (the quick – yet fascinating story of which can be read here), and since 1983 (when the […]

January 13, 2016 - 3 minutesmins - By Dani Bancroft

cellectis ucart19 nature cancer car t cell leukemia crs cytokine

News and Trends 12 Jan 2016

Cellectis has Discovered an ‘On-Switch’ to Make CAR-T Safer and Better Controlled

Cellectis researchers have managed to come up with a new CAR architecture with a small-molecule triggered ‘on-switch’, permitting better control and safety in CAR T-cell therapy, as published in Nature. As we discussed during our interview with Andre Choulika, CEO of Cellectis, last month, one major drawback to CAR-T treatment for cancer is the lack of […]

January 12, 2016 - 3 minutesmins - By Dani Bancroft

prostate cancer trod encage leuven ucl vesalius

News and Trends 11 Jan 2016

TROD’s MedTech for Prostate Cancer Kills Tumor Cells with Radio Waves

TROD Medical, the medical device company developing tools for focal ablation, today announced that it has received CE Mark Approval for its Encage device. Encage is a breakthrough in treatment for prostate cancer, one of the most common soft tissue cancers in the world with around 240,000 new cases every year in the US alone. […]

January 11, 2016 - 2 minutesmins - By Dani Bancroft

innate pharma immunooncology biotech cancer orega sanofi

News and Trends 11 Jan 2016

A French Biotech is Monopolising Immuno-Oncology with Big Euro Deals

Marseille’s Innate Pharma is building an Immuno-Oncology Monopoly, deal by deal. Selling to the French Pharma Giant, Sanofi, this 112 employee biotech has used their Sanofi-income to buy up Lyon-based Orega Biotech‘s checkpoint inhibitor program. Sanofi and Innate Pharma will work together on the generation and evaluation of up to two bispecific NK cell engagers, […]

January 11, 2016 - 3 minutesmins - By Dani Bancroft

transgene pecvex oncolytic liver cancer lee pharma

News and Trends 11 Jan 2016

Transgene shares jump 50% in 2 days After Announcing Phase III Trial for Liver Cancer

This multinational Phase III Trial for an Oncolytic Immunotherapy for Advanced Liver Cancer could be what really defines French Transgene as the underdog which finally sprang to fame. Transgene, in Strasbourg, was founded in 1979, as France’s oldest Biotech (only 3 years after Genentech was born on the other side of the Atlantic). However, unlike Genentech, […]

January 11, 2016 - 3 minutesmins - By Dani Bancroft

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

France

Meet the CEO of Europe’s Leading Microbiome Biotech

From Belgium: 3D-Bioprinted ‘Waffle’ to Fix Broken Bones

This Young CEO is Making Biotech Popular in France

Viral Immunotherapy Trial Failure Causes French Biotech Stocks to Drop 43%

French Investor Leads €60M Financial Round for the Future of DNA Synthesis

Fighting Lupus with an Autoimmune Disease Vaccine that Uses Limpet Proteins

How is Using Amoeba to Fight off Legionella in Water Tanks a White Biotech Solution?

A Phase II HIV Antiviral from France Has Promising Results

Cellectis has Discovered an ‘On-Switch’ to Make CAR-T Safer and Better Controlled

TROD’s MedTech for Prostate Cancer Kills Tumor Cells with Radio Waves

A French Biotech is Monopolising Immuno-Oncology with Big Euro Deals

Transgene shares jump 50% in 2 days After Announcing Phase III Trial for Liver Cancer

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!